REPORT ID 1581

EMEA (Europe, Middle East and Africa) Specialty Injectable Generics Market Report 2017

Publish Date
06-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the EMEA Specialty Injectable Generics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Specialty Injectable Generics for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Specialty Injectable Generics market competition by top manufacturers/players, with Specialty Injectable Generics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Fresenius
    Mylan N.V.
    Teva Pharmaceutical
    Hikma Pharmaceuticals
    Novartis AG
    Uman Pharma
    Baxter
    Par Pharmaceutical
    Sagent Pharmaceuticals
    Teligent

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Type I
    Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Infectious Diseases
    Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Specialty Injectable Generics Market Report 2017
1 Specialty Injectable Generics Overview
    1.1 Product Overview and Scope of Specialty Injectable Generics
    1.2 Classification of Specialty Injectable Generics
        1.2.1 EMEA Specialty Injectable Generics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Specialty Injectable Generics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 
        1.2.4 
    1.3 EMEA Specialty Injectable Generics Market by Application/End Users
        1.3.1 EMEA Specialty Injectable Generics Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Infectious Diseases
        1.3.6 Autoimmune Disorders
    1.4 EMEA Specialty Injectable Generics Market by Region
        1.4.1 EMEA Specialty Injectable Generics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Specialty Injectable Generics (2012-2022)
        1.5.1 EMEA Specialty Injectable Generics Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Specialty Injectable Generics Revenue and Growth Rate (2012-2022)

2 EMEA Specialty Injectable Generics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Specialty Injectable Generics Market Competition by Players/Manufacturers
        2.1.1 EMEA Specialty Injectable Generics Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Specialty Injectable Generics Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Specialty Injectable Generics Sale Price by Players (2012-2017)
    2.2 EMEA Specialty Injectable Generics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Specialty Injectable Generics Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Specialty Injectable Generics Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Specialty Injectable Generics Sale Price by Type (2012-2017)
    2.3 EMEA Specialty Injectable Generics (Volume) by Application
    2.4 EMEA Specialty Injectable Generics (Volume and Value) by Region
        2.4.1 EMEA Specialty Injectable Generics Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Specialty Injectable Generics Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Specialty Injectable Generics Sales Price by Region (2012-2017)

3 Europe Specialty Injectable Generics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Specialty Injectable Generics Sales and Value (2012-2017)
        3.1.1 Europe Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
    3.2 Europe Specialty Injectable Generics Sales and Market Share by Type
    3.3 Europe Specialty Injectable Generics Sales and Market Share by Application
    3.4 Europe Specialty Injectable Generics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Specialty Injectable Generics Sales Volume by Countries (2012-2017)
        3.4.2 Europe Specialty Injectable Generics Revenue by Countries (2012-2017)
        3.4.3 Germany Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        3.4.4 France Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        3.4.5 UK Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        3.4.6 Russia Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        3.4.7 Italy Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Specialty Injectable Generics Sales and Growth Rate (2012-2017)

4 Middle East Specialty Injectable Generics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Specialty Injectable Generics Sales and Value (2012-2017)
        4.1.1 Middle East Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
    4.2 Middle East Specialty Injectable Generics Sales and Market Share by Type
    4.3 Middle East Specialty Injectable Generics Sales and Market Share by Application
    4.4 Middle East Specialty Injectable Generics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Specialty Injectable Generics Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Specialty Injectable Generics Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        4.4.4 Israel Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        4.4.5 UAE Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        4.4.6 Iran Specialty Injectable Generics Sales and Growth Rate (2012-2017)

5 Africa Specialty Injectable Generics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Specialty Injectable Generics Sales and Value (2012-2017)
        5.1.1 Africa Specialty Injectable Generics Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Specialty Injectable Generics Revenue and Growth Rate (2012-2017)
    5.2 Africa Specialty Injectable Generics Sales and Market Share by Type
    5.3 Africa Specialty Injectable Generics Sales and Market Share by Application
    5.4 Africa Specialty Injectable Generics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Specialty Injectable Generics Sales Volume by Countries (2012-2017)
        5.4.2 Africa Specialty Injectable Generics Revenue by Countries (2012-2017)
        5.4.3 South Africa Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Specialty Injectable Generics Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Specialty Injectable Generics Sales and Growth Rate (2012-2017)

6 EMEA Specialty Injectable Generics Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Specialty Injectable Generics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Fresenius
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Specialty Injectable Generics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Fresenius Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Mylan N.V.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Specialty Injectable Generics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Mylan N.V. Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Teva Pharmaceutical
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Specialty Injectable Generics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Hikma Pharmaceuticals
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Specialty Injectable Generics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Specialty Injectable Generics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Uman Pharma
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Specialty Injectable Generics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Uman Pharma Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Baxter
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Specialty Injectable Generics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Baxter Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Par Pharmaceutical
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Specialty Injectable Generics Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Par Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sagent Pharmaceuticals
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Specialty Injectable Generics Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Teligent

7 Specialty Injectable Generics Manufacturing Cost Analysis
    7.1 Specialty Injectable Generics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Specialty Injectable Generics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Specialty Injectable Generics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Specialty Injectable Generics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Specialty Injectable Generics Market Forecast (2017-2022)
    11.1 EMEA Specialty Injectable Generics Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Specialty Injectable Generics Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Specialty Injectable Generics Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Specialty Injectable Generics Price and Trend Forecast (2017-2022)
    11.2 EMEA Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Specialty Injectable Generics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Specialty Injectable Generics Sales Forecast by Type (2017-2022)
    11.7 EMEA Specialty Injectable Generics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer